• Intervention
    Does the addition of immune-modulating enteral nutrition to enteral feeding of severely ill ICU patients impact mortality?
    • Conclusion

      The addition of immune-modulating EN to enteral feeding of severely ill ICU patients may be associated with increased mortality, though adequately powered trials have not been conducted.   

       

    • Grade: III
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.
    Does the addition of immune-modulating enteral nutrition to enteral feeding of moderate to less severely ill ICU patients impact mortality?
    • Conclusion

      The addition of immune-modulating EN to enteral feeding of moderate or less severely ill ICU patients demonstrates no effect on mortality.

    • Grade: II
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.
    Does the addition of immune-modulating enteral nutrition to enteral feeding impact infectious complications in critically ill ICU patients?
    • Conclusion

      The use of immune-modulating EN in some critically ill ICU patients has shown benefit in reducing infectious complications in some patients.

       

    • Grade: III
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.
    Does the addition of immune-modulating enteral nutrition to enteral feeding impact length of hospital stay in critically ill ICU patients?
    • Conclusion

      The addition of immune-modulating EN to enteral feeding of critically ill ICU patients has limited impact on LOS.

    • Grade: II
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.
    Does the addition of immune-modulating enteral nutrition to enteral feeding impact days on mechanical ventilation in critically ill ICU patients?
    • Conclusion

      The addition of immune-modulating EN to enteral feeding of critically ill ICU patients is not associated with reduced number of days on mechanical ventilation.

    • Grade: II
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.
    Does the addition of immune-modulating enteral nutrition to enteral feeding impact cost of medical care in critically ill ICU patients?
    • Conclusion

      The addition of immune-modulating EN to enteral feeding of critically ill ICU patients is not associated with reduced cost of medical care.  

       

    • Grade: III
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.